NURECA

The stock has been placed in Additional Surveillance Measure (ASM) list LTASM - I (13).

Nureca Ltd.

NSE: NURECA

BSE: 543264

Sector: Healthcare

Industry Group: Healthcare Equipment & Supplies

Industry: Medical Equipment & Supplies

340.00+1.4 (+0.40%)

7 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

43.4 / 100

Value Score

34.0 / 100

Price Momentum Score

78.8 / 100

QVM Score

50.1 / 100

Key Metrics

Market Cap

324.43

P/E (TTM)

74.80

P/B

1.79

P/S (TTM)

2.12

EV/EBITDA

24.95

CAPE (5Y)

323.43

ROE (TTM)

1.11

ROCE (TTM)

3.42

ROA (TTM)

1.03

Avg 3Y ROE

0.21

Earnings 3Y CAGR

Sales 3Y CAGR

12.68

Sales 5Y CAGR

-7.19

Debt/Equity

0.01

Consensus TP

Strong Buy %

Promoter Holding

68.09

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Nureca Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 78.8 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

78.8 / 100

Strong revenue growth and above median growth of market

The company delivered strong revenue growth of 23.92% for 12-month ended 30 Jun 2026 and the growth was 12.83 percentage points higher than median growth of market

What is Sales growth (1Y)?

Median: 11.09

Value 23.92

-637.47179204992

Strong EPS growth and above median growth of market

The company delivered strong EPS growth of 345543.0% for 12-month ended 30 Jun 2026 and the growth was 345537.53 percentage points higher than median growth of market

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.01 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.02 in the last 1 year

What is Debt to Equity?

Company's earnings are of high quality

Earnings quality score of 79.2 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

79.2 / 100

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 74.8 indicates that the stock is expensive on a standalone basis and is at a 158.56% premium to industry median P/E

What is P/E Ratio?

Median: 28.93

Value 74.8

7.57116.02

Low but stable ROE

The company reported low ROE of 1.11% for 12-month ended 30 Jun 2026 and ROE improved marginally by 67 bps from 1 year ago

What is ROE (FY)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Low operating margin but improving trend

The company reported low operating margin of 6.84% for 12-month ended 30 Jun 2026 but operating margin improved by 1327 bps from 1 year ago

What is Operating profit margin?

Financial Snapshot

See detailed analysis

Multi-year trends for Nureca Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Nureca Ltd. Shareholding Pattern

Quarterly breakdown of Nureca Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	70.00	70.00	70.00	70.00	70.00	70.00	70.00	62.98	62.98	62.98	63.24	63.24	63.24	63.24	63.77	64.06	64.30	64.33	64.97	68.09	68.09	68.09
Indian Promoter	70.00	70.00	70.00	70.00	70.00	70.00	70.00	62.98	62.98	62.98	63.24	63.24	63.24	63.24	63.77	64.06	64.30	64.33	64.97	68.09	68.09	68.09
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	18.60	19.17	19.09	18.54	17.45	17.26	2.22	0.10	0.10	0.10	0.10	0.07	0.07	0.07	0.69	0.36	1.07	0.07	0.07	0.08	0.48	0.31
Mutual Funds / UTI	1.63	1.32	1.34	1.35	1.35	1.35	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	4.08	4.08	4.08	4.08	3.88	3.88	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	10.51	12.42	13.57	13.02	12.22	12.04	1.67	0.10	0.10	0.10	0.10	0.07	0.07	0.07	0.69	0.36	1.07	0.07	0.07	0.09	0.28	0.11
Other Institutions	2.38	1.36	0.09	0.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.20	0.20
Non-Institution	11.40	10.83	10.92	11.47	12.55	12.74	27.77	36.91	36.91	36.91	36.66	36.69	36.69	36.69	35.53	35.58	34.62	35.60	34.96	31.83	31.43	31.60
Bodies Corporate	6.44	5.88	4.66	4.74	3.58	3.76	0.53	0.53	0.75	0.71	0.52	1.10	0.98	0.55	0.55	0.53	0.63	0.76	0.92	0.33	0.63	0.59
Others (incl. Retail) No. of shareholders	4.96 7,786	4.95 10,009	6.26 12,561	6.73 15,399	8.97 26,059	8.98 26,051	27.24 63,761	36.38 61,863	36.16 58,427	36.20 55,435	36.14 52,133	35.59 49,475	35.71 45,887	36.14 43,711	34.98 41,886	35.05 41,218	33.99 39,210	34.84 37,980	34.04 37,370	31.50 35,722	30.80 34,479	31.01 33,907

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Nureca Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Nureca Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
SAURABH GOYAL Director	March-2025	Market Purchase (Acquisition) 31st Mar 2025	31.82 %	₹ 211.37	6.10 k	₹ 12.90 lac
SAURABH GOYAL Director	March-2025	Market Purchase (Acquisition) 31st Mar 2025	31.82 %	₹ 211.37	6.10 k	₹ 12.90 lac
VIVEK GUPTA Designated Person	March-2025	Market Purchase (Acquisition) 31st Mar 2025	0.02 %	₹ 211.59	945.00	₹ 2.00 lac
VIVEK GUPTA Designated Person	March-2025	Market Purchase (Acquisition) 28th Mar 2025	0.02 %	₹ 216.09	950.00	₹ 2.05 lac
ARYAN GOYAL Promoter Group	March-2025	Market Purchase (Acquisition) 17th Mar 2025	3.68 %	₹ 233.75	5.32 k	₹ 12.44 lac
VIVEK GUPTA Designated Person	February-2025	Market Purchase (Acquisition) 14th Feb 2025	0.00 %	₹ 271.77	1.10 k	₹ 2.99 lac
VIVEK GUPTA Designated Person	February-2025	Market Purchase (Acquisition) 4th Feb 2025	0.00 %	₹ 289.25	500.00	₹ 1.45 lac
SAURABH GOYAL Promoter & Director	February-2025	Market Purchase (Acquisition) 3rd Feb 2025	31.77 %	₹ 291.06	5.00 k	₹ 14.55 lac
SAURABH GOYAL Promoter & Director	January-2025	Market Purchase (Acquisition) 31st Jan 2025	31.67 %	₹ 292.72	10.00 k	₹ 29.27 lac
Aryan Goyal Promoter Group	December-2024	Market Purchase (Acquisition) 30th Dec 2024	3.58 %	₹ 291.51	10.00 k	₹ 29.15 lac

Corporate Actions

History of Nureca Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Others
Ex-date: 12th Dec 2025Announced on: 28th Nov 2025
On Market tender offer.
Dividend₹ 3/share
Record date: 25th Feb 2022Ex-date: 24th Feb 2022
Announced on: 12th Feb 2022
Dividend₹ 2/share
Record date: 22nd Sep 2021Ex-date: 21st Sep 2021
Announced on: 16th Jun 2021

Company Profile

Overview of Nureca Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Nureca Limited is a specialist in home healthcare and wellness products. Its products serve individuals, caregivers and medical practitioners across the globe. It offers a range of products specialized in home-based, non-invasive digital diagnosis and prevention of lifestyle diseases. Its range of p...

Key personnel

Mr. Chander Kant

Chief Financial Officer

Ms. Nishu Kansai

Compliance Officer, Company Secretary

Mr. Gurvikram Singh

Assistant Manager - Investors Relations and Corporate Affairs

Mr. Saurabh GoyalD

Chairman of the Board, Managing Director

Ms. Smita GoyalD

Additional Whole Time Director

Mr. Rajinder SharmaD

Whole Time Director

Mrs. Ruchita AgarwalD

Non-Executive Independent Director

Mr. Vijay Kumar SharmaD

Non-Executive Independent Director

View all

Incorporated on

02 Nov 2016

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

154

IPO date

25 Feb 2021

Free Float

30,41,248

Address

Frequently Asked Questions

What is the current share price of Nureca Ltd.?

The current share price of Nureca Ltd. is ₹ 340.00 as of 7 Aug 2026.

What is the market capitalisation of Nureca Ltd.?

The market capitalisation of Nureca Ltd. stands at ₹ 324.43 Cr.

What is the PE ratio of Nureca Ltd.?

The Price-to-Earnings (PE) ratio of Nureca Ltd. is 74.80 as of the latest trailing twelve months data.

What is the ROE and ROCE of Nureca Ltd.?

Nureca Ltd. has a Return on Equity (ROE) of 1.11% and a Return on Capital Employed (ROCE) of 3.42% as per the latest financial reports.

What is the 52-week high and low of Nureca Ltd.?

The 52-week high of Nureca Ltd. is - and the 52-week low is -.

What is the dividend yield of Nureca Ltd.?

The dividend yield of Nureca Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Nureca Ltd.?

Foreign Institutional Investors (FII) hold 0.11%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 31.01% of Nureca Ltd. shares.

What sector does Nureca Ltd. belong to?

Nureca Ltd. operates in the Healthcare sector.

What is the beta of Nureca Ltd.?

The beta of Nureca Ltd. is 1.16, indicating its price volatility relative to the broader market. Over the past 1 year, Nureca Ltd. has delivered an absolute return of 41.25%.

What is the RSI of Nureca Ltd.?

The 14-day Relative Strength Index (RSI) of Nureca Ltd. is 68.82, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Nureca Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Nureca Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Corporate Actions

Stock Analysis

Holdings and Presence

Company Profile